Lab analyst GC-MS method development

Braine-l'Alleud, Wallonia, BE

In-personFull time roleEarly Career

7 months ago

About the Job

You will be part of a team working mainly with GC-MS/MS instruments to identify and quantify impurities in different types of pharmaceuticals products. Your responsibilities will include:

You will be responsible for instrumental chromatographic analysis (GC-MS/MS).
Identifying all technical problems or malfunctions, ensure the analysis, interpretation of results and be proactive in developing solutions.
Interpreting the data generated and report your conclusion to the client.
Participating in investigations.
Reviewing data generated by others analyst.
Participating in laboratory management tasks (storage, cleaning, drafting of procedures, preparation of laboratory reagents, etc.)
Participating in the sample management
Adhering to the quality system requirements and ensure GMP and GDP standards; also adhere to general and specific environmental, health and safety guidelines.

About the Company

Eurofins

Luxembourg, Luxembourg

5000 +

Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins is a global leader in food, environmental, pharmaceutical and cosmetic product testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. Since 1987, Eurofins has grown from one laboratory in Nantes, France to ca. 62,000 staff across a network of independent companies in 62 countries, operating over 900 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.